The effect of generic market entry on antibiotic prescriptions in the United States | Nature Communications
How Generic Drugs, Patents, and Price Controls Affect Markets | NBER
A Method for Approximating Future Entry of Generic Drugs
Generic pharmaceutical price decay - Wikipedia
The consequences of generic entry : price , promotional effort and market share PRELIMINARY | Semantic Scholar
A Method for Approximating Future Entry of Generic Drugs
Generic Competition and Market Exclusivity Periods in Pharmaceuticals
Generic Versus Brand-Name Drugs: What's the Difference?
Estimating the Causal Effect of Entry on Generic Drug Prices Using Hatch–Waxman Exclusivity | SpringerLink
Association between US Pharmacopeia (USP) monograph standards, generic entry and prescription drug costs | PLOS ONE
![PDF] The Effect of Generic Drug Competition on Generic Drug Prices During the Hatch-Waxman 180-Day Exclusivity Period | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/86e69913e01a8f5a08924a3495d9f00a4aea328e/35-Figure1-1.png "PDF] The Effect of Generic Drug Competition on Generic Drug Prices During the Hatch-Waxman 180-Day Exclusivity Period | Semantic Scholar")
PDF] The Effect of Generic Drug Competition on Generic Drug Prices During the Hatch-Waxman 180-Day Exclusivity Period | Semantic Scholar
Effects of Market Size on Any Generic Entry and No. of Generic... | Download Table
Full article: Continuing trends in U.S. brand-name and generic drug competition
The effect of inertia on brand-name versus generic drug choices - ScienceDirect
Estimating The Cost Of Delayed Generic Drug Entry To Medicaid | Health Affairs
Generic pharmaceutical price decay - Wikipedia
The unexpected consequences of generic entry - ScienceDirect
Impact of generic drug entry on cost-effectiveness analysis - Document - Gale Academic OneFile
The Second Look at Drug Patents Act of 2020 Senators Patty Murray (D-WA) and John Cornyn (R-TX)
GENERICS - BRIDGING THE GAP Or BALANCING COST AND ACCESS - ppt download
PDF) The Empirical Effect of Generic Competition on Brand-Name Molecules in the U.S. Pharmaceutical Market | Nicholas Debany - Academia.edu
WSGR ALERT FTC ISSUES FINAL AUTHORIZED GENERIC REPORT
Estimating the Causal Effect of Entry on Generic Drug Prices Using Hatch–Waxman Exclusivity | SpringerLink
Generic entry dramatically reduces branded product sales - Equitable Growth
